![Kari Grønås](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kari Grønås
Director/Miembro de la Junta en
SPAGO NANOMEDICAL AB
.
Perfil
Kari Grønås is currently Chairman at Norwegian Cancer Society and Lungekreftforeningen.
Ms. Grønås is Director at Oncoinvent ASA since 2024, Independent Director at Spago Nanomedical AB since 2018, Managing Director & Director at K & K AS since 2012, and Director at Arxx Therapeutics AS.
Former roles include Chairman at Norwegian Pharmaceutical Society, Director at Oncopeptides AB, Lytix Biopharma AS, SoftOx.
Solutions AS, Ultimovacs ASA, and Oncoinvent ASA (Old).
Ms. Grønås was Independent Non-Executive Director at Oncoinvent ASA from 2016 to 2019 and Senior Vice President-Operations at Algeta ASA. Education includes a graduate degree from the University of Oslo.
Cargos activos de Kari Grønås
| Empresas | Cargo | Inicio |
|---|---|---|
| SPAGO NANOMEDICAL AB | Director/Miembro de la Junta | 01/01/2018 |
| ONCOINVENT ASA | Director/Miembro de la Junta | 01/01/2024 |
K & K AS
 K & K AS Miscellaneous Commercial ServicesCommercial Services Provides business and management consulting services | Director Ejecutivo | 21/05/2012 |
Norwegian Cancer Society | Presidente | - |
Arxx Therapeutics AS
 Arxx Therapeutics AS BiotechnologyHealth Technology Develops therapeutics for fibrotic diseases | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Kari Grønås.
| Empresas | Cargo | Fin |
|---|---|---|
| ONCOINVENT ASA | Director/Miembro de la Junta | 13/03/2019 |
Oncoinvent AS
 Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Director/Miembro de la Junta | - |
| ONCOPEPTIDES AB | Director/Miembro de la Junta | - |
Ultimovacs ASA
 Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Director/Miembro de la Junta | - |
| ░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
Formación de Kari Grønås.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
52
Relaciones de 1er grado
13
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 13 |
|---|---|
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
University of Oslo
 University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
Lytix Biopharma AS
 Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies | Health Technology |
BerGenBio ASA
 BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Spago Nanomedical AB
 Spago Nanomedical AB BiotechnologyHealth Technology Acts as a biotechnology company | Health Technology |
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Health Technology |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Health Technology |
Norwegian Pharmaceutical Society | |
SoftOx Solutions AS
 SoftOx Solutions AS Miscellaneous Commercial ServicesCommercial Services Develops and manufactures non-toxic & antiseptic medicines | Commercial Services |
K & K AS
K & K AS Miscellaneous Commercial ServicesCommercial Services Provides business and management consulting services | Commercial Services |
Norwegian Cancer Society | |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Develops therapeutics for fibrotic diseases | Health Technology |
- Bolsa de valores
- Insiders
- Kari Grønås
